Cordyceps Sinensis, also known as "Winter Worm, Summer Grass", is a rare and exotic medicinal mushroom known in China for centuries. Two thousand years ago in the Himalayan Mountains of Tibet, local herdsmen noticed the unusual vigor of their yaks grazing on Cordyceps. 

The cap-less mushroom they found was later recognized as a natural wonder.
 
Cordyceps sinensis has been used in traditional Chinese medicine as a cure-all. Chinese use it to heal lung, liver, heart and kidney diseases, to treat fatigue, cancer, as well as male and female sexual dysfunction, to relieve pain, to enhance overall health, and to promote longevity.

 

Due to its rarity, and legendary efficacy against a variety of health conditions, Cordyceps has held, and continues to hold, a highly esteemed position in the vast ranks of Chinese herbal remedies.

 

Most people in the West have come to know this once rare herbal medicine in only the last twenty years or so, thanks to the advancement in modern cultivation technology. Those techniques have dramatically lowered the cost of consumption, and have allowed for more in-depth research into Cordyceps' healing potential.

Today, modern scientific research has proven what Chinese practitioners have noted for centuries. Numerous clinical trials have proceeded to scientifically prove that Cordyceps works well in treating and healing a myriad of medical problems.

DNA mapping and cloning are cutting-edge scientific techniques resulting from biotech advances, use of computers, and new understanding of human molecular structures.  

 

Marvlix is a new product generated from Cordyceps sinensis through these latest scientific breakthroughs.

 

Marvlix was developed by means of Elixir Industry's proprietary technology, which applies nanotechnology to a bio-enhanced extraction process. The technology utilizes electro-potential method to extract selected molecules preferentially, on the basis of predefined molecular profiles, and then bio-activates the compounds extracted. The process completely eliminates heavy metals, contaminants and toxic compounds commonly found in traditional herbal products, while retaining all the beneficial substances in Cordyceps. In comparison with traditional Cordyceps products, Marvlix has demonstrated these unparalleled advantages:

• Alternative Cancer Treatment
• Anti-Aging Effects
• Alternative Diabetes Treatment
• Liver Health and High Cholesterol
• Heart Health
• Kidney Health
• Lung Health
• Reduction of Drug Toxicity
• Enhance overall health, and to promote longevity

Traditional Cordyceps products provide only a small portion of the active ingredients from Cordyceps sinensis. The majority of the active elements are lost during the cultivation and production process, either because of exposure to heat and high pressure, or due to use of chemical solutions for extraction.

As a result, traditionally cultivated Cordyceps products deliver only a fraction of the benefits provided by their wild counterparts. That's why wild Cordyceps products often sell for hundreds of times more than cultivated Cordyceps products.

The Elixir Industry method avoids the problems associated with traditional Cordyceps extraction. The use of nanotechnology allows us to penetrate the cell wall to release nutrients that were lost through the traditional process. Active compounds are then removed one by one at the molecular level, based on predefined molecular profiles. In this way, we are able to preserve the full spectrum of active elements that Cordyceps  can provide.

This is a great achievement, even though scientists have successfully proven the benefits of Cordyceps on internal organs such as heart, liver, lung and kidney, they have not been able to find out which elements are responsible for each of the miraculous benefits provided by Cordyceps. Therefore it is critical not to miss any active ingredient.

Marvlix extracts only the useful ingredient from Cordyceps sinensis. And the extraction is done using nanotechnology and a bio-enhanced extraction method. This ensures Marvlix doesn't contain anything a traditional mushroom product may include, certainly no fungus. In fact, Marvlix boosts immunine system, helping body to fight candida more effectively.

Our Formula Contains a Much Higher Concentration of Active Ingredients

Our molecular-based extraction process generates a much higher concentration of active ingredients than that found in Cordyceps products produced by the traditional method. Test results show that a single Marvlix capsule delivers the same potency as 12 - 17 ordinary Cordyceps capsules.

Marvlix Offers High Bioavailability

Marvlix works at the cellular level. The particles are so small that they can be assimilated effortlessly. Many who experience problems digesting other nutritional supplements will find the opposite to be true with Marvlix.

Purity - No Heavy Metals or Other Contaminates

We all know that traditional Chinese herbs work. But the fact that many of those products contain heavy metal or other harmful materials has disturbed many people. With Marvlix that is no longer an issue. Marvlix is produced using a unique extraction process that extracts only the active ingredients. Nothing else is included in the final product. 

While the benefits you are getting is multiplied, your mind can be totally at ease as you can be sure that you won't get any contaminates commonly found in traditional Cordyceps products.

Positive Results of those who have used Marvlix with Significant Health Improvements

Marvlix has been available in Asia for about a year now. The response was so overwhelming that the company decided to distribute the product in North America ahead of the original schedule. 

Between August and December 2006, we arranged for a small group of customers to test use Marvlix. All 36 participants in the test reported that Marvlix had improved their overall well-being. While the time frame was too short for a conclusive study, a majority of the users identified improved body functions that could be attributed to Marvlix. 

Most reported more energy, better sleep, sharper vision, easier breath and fewer trips to the bathroom. Those observations are clearly indications of improved health conditions of major organs in the body, including kidney, lung, liver and heart. 

Seven individuals with diabetes reported that they were able to reduce their medication, as they no longer need as much to maintain proper glucose ratios. Others with elevated cholesterol reported that their levels returned to normal after using Marvlix for about two months. Two subjects who were taking chemotherapy found that hair loss and other side effects were significantly reduced. 

In this section we present the benefits of Marvlix that have been proven by numerous research studies and clinical trials undertaken by scientists from all over the world during the past two decades.

The medical applications of Cordyceps center on the key functions of essential organs, including (but not limited to) the lung, kidney, liver and heart. Cordyceps is also recommended as an aid to treatment of cancer, diabetes, high cholesterol, the effects of aging, and the reduction of drug toxicity. 
 

Identified agents, such as adenosine, cordycepin, cordycepic acid, the polysaccharides, and vitamins and trace elements, are believed to be at least partially responsible for the well-documented beneficial effects of Cordyceps usage.

While researchers are still looking for more beneficial agents found in the fungus, numerous clinical trials have proven scientifically that Cordyceps works well in treating and healing a myriad of medical problems.    

 

Learn how Marvlix can help these specific diseases below
Kidney, Lung, Heart, Liver and Cholesterol, 
Diabetes, Anti-Aging, Cancer, Drug Toxicity 

Modern science has confirmed that kidney health is indeed critical for the overall health of the body. Kidneys failure is often linked to problems occurring in other organs and systems that lead to diseases and common ailments. High blood pressure, fatigue, impotence, joint and back pain, even ringing in the ears can all be symptomatic of unhealthy kidneys.

Many regard kidney health as the key to longevity. And Marvlix, Elixir Industry's proprietary production of Cordyceps sinensis, is the key to kidney health.

 

While we don't have a complete understanding of the reasons that Cordyceps has such a remarkable effect on kidney health, scientists have made great progress in this regard over the last 10 years. In 1998, Dr. Zhou and his team discovered that the renal health-enhancing potential of Cordyceps may come from its ability to increase 17-hydroxy-corticosteroid and 17-ketosteriod levels.

 

Chronic renal failure is a life-threatening condition that often affects the elderly. In a 1992 study of 51 patients with chronic renal failure, Dr. Guan and his colleagues found that the group of patients receiving 3-5 grams of Cordyceps sinensis per day showed significantly improved kidney function and overall immune function, as compared to the placebo group.

Patients with kidney problems often suffer from hypertension, proteinuria and anemia. In a study involving such patients, a 15% decrease in blood pressure was observed after one month on Cordyceps. Urinary protein was also significantly reduced. In addition, an increase in superoxide dismutase was observed and documented. The study further suggested an increase in the free radical-scavenging capability of oxygen in the bloodstream, which would result in reduced oxidative cellular damage.

 

In another clinical study, 57 patients with gentamicin-induced kidney damage were treated with 4.5 grams of Cordyceps per day or by other, more conventional methods. After six days, the Cordyceps group had recovered 89% of normal kidney function, while the control group had recovered an average of only 45% of normal kidney function. The time-to-recovery was also significantly shorter in the Cordyceps group as compared to the control group.

 

Cordyceps sinensis has been viewed as a promoter of respiratory health in China for more than a thousand years. And latest clinical studies have proven Cordyceps' ability to enhance oxygen utilization and cellular oxygen uptake. Marvlix has taken this benefit to another level.
 
In low-oxygen environments, mice treated with Cordyceps survived up to three times longer than those left untreated, evidencing more efficient oxygen utilization in those that were treated. Its long history as prevention and treatment of altitude sickness also lends credence to the theory that Cordyceps promotes more efficient oxygen utilization.

 

Cordyceps sinensis has been used effectively to treat Bronchitis, Asthma, and Chronic Obstructive Pulmonary Disease (COPD). It has been shown to inhibit tracheal contractions (especially important for asthma patients) by promoting increased airflow to the lungs. In addition, Cordyceps' anti-inflammatory properties bring further relief to asthma patients, whose airways become obstructed, due to an allergic reaction resulting in swelling of the bronchial pathways.
Lung Health - COPD, Bronchitis and Asthma
 

In a clinical trial involving 50 asthma patients, Cordyceps averaged 81.3% effectiveness against asthma symptoms in just five days, while conventional antihistamines proved only 61.1% effective after an average of nine days.

 

Extensive clinical studies have been conducted, treating a wide variety of respiratory illnesses, including asthma, COPD, and bronchitis, with Cordyceps alone or as an adjunct to standard antibiotic therapy, and Cordyceps has proven beneficial for all these indications. What has been observed for centuries in Asia — that Cordyceps improves respiratory function — is now proven and accepted scientific fact.

 

One of the most important benefits of Cordyceps is its ability to stabilize the heart beat and correct cardiac arrhythmias. This fungus stands at the top of the list of treatments for this serious condition in China today.

 

The mechanism of effectiveness is only partly understood. One study pointed to the presence of adenosine, and Cordyceps contains a significant amount of adenosine, deoxyadenosine, and related adenosine-type nucleotides. These compounds are known to have great positive impact on coronary and cerebral circulation.

 
Cordyceps doesn't interfere with any arrhythmia medication. With low toxicity, Cordyceps is an excellent choice for heart arrhythmias.

 

Historically, Cordyceps has been used to treat many other heart conditions. It benefits the vascular system by improving circulation, regulating blood pressure, and strengthening the heart muscle.
 

Cordyceps also helps prevent the oxidation of LDL cholesterol and acts as a blood thinner, to work against plaque or clot formation.

 

In a long-term study of patients with chronic heart failure, continuous use of Cordyceps in combination with conventional treatments promoted an increase in the overall quality of life. This included general physical condition, mental health, and cardiac function, compared to the control group.

Marvlix improves blood flow and delivers more oxygen throughout the body, which naturally increases liver function and enhances the liver's ability to fend off diseases like hepatitis as well as the condition of high cholesterol.

 

The liver regulates cholesterol metabolism, and high cholesterol can be a symptom of liver dysfunction. Promoting liver health and function can reduce the bad cholesterol and increase the level of good cholesterol.
 
There is a large body of research confirming the benefits of Cordyceps on liver function. And, in Asia, Cordyceps is commonly used as an adjunct in the treatment of hepatitis B and C.

In one clinical study, Cordyceps was used with the antiviral lamivudine for the treatment of hepatitis B. The group receiving Cordyceps had much better outcomes in a shorter period of time than the control group, which was treated by lamivudine alone.

 

In another study of 22 patients with post-hepatic cirrhosis, all patients showed dramatic improvement in liver function after three months of 6-9 grams of Cordyceps administered daily.

 

Hypercholesterolemia (high cholesterol) is a result of metabolic dysfunction and an indicator of increased cardiovascular risk. The liver is responsible for cholesterol production and elimination; therefore, it stands to reason that any disorder of the liver could affect the blood levels of cholesterol and triglyceride.

 

Through many formal trials and clinical observations, administration of Cordyceps has been associated with cholesterol and triglyceride reduction and a healthy increase in the ratio of HDL to LDL cholesterol. 

Marvlix improves blood glucose metabolism and increases insulin sensitivity, because it enables the liver to produce more glucose-regulating enzymes.

 

Marvlix can be used alone or in conjuction with other treatment to regulate blood sugar levels and has been clinically proven to be more effective than prescription drugs in blood sugar management.

Diabetes is a serious, widespread health issue, especially among populations that rely on the Western diet. A large body of research has been conducted on the beneficial effects of Cordyceps on the blood glucose metabolism system and on its potential as a blood sugar regulation agent. The results are convincing.

 

In one clinical study, 95% of patients treated with 3 grams Cordyceps daily saw improvement in their blood sugar measurement, while those that received mainstream medical treatment showed only 54% improvement.

 

In a trial conducted by Kiho in 2000, Cordyceps was found to lower blood sugar levels in genetically diabetic animals. Another trial by Dr. Zhao and his team in 2002 showed that Cordyceps improves blood glucose metabolism and increases insulin sensitivity in normal animals. A study by Hao and Chen in 2002 concluded that Cordyceps positively affects blood sugar metabolism in animals with chemically induced diabetes.

 

In another clinical study, researchers found that, for non-diabetic patients treated with 3 grams Cordyceps daily, the normal blood sugar change curve was significantly flattened. In other words, for these subjects, the blood sugar did not go as high as usual after eating, and it did not drop down as low as usual between meals. This study provided further evidence that Cordyceps has the ability to regulate blood sugar levels.

 

A common thread among these results is the increase in insulin sensitivity and in the livers' output of the glucose regulating enzymes. Regardless of the origin or classification, it appears that Cordyceps is a great treatment for diabetes, either as a single agent or in conjunction with prescription drug therapy, and has been demonstrated to stabilize blood sugar levels even in non-diabetic test subjects.  

One quickly noted benefit of Marvlix is that it provides anti-aging, fatigue reducing effects.

 

Marvlix works as an antioxidant, increasing cellular formation, especially among seniors. It promotes more restful sleep, soothes the nervous system, and reduces anxiety. In Asia, Cordyceps is commonly used as an overall rejuvenator for patients recovering from serious illness.

  
Aging is thought to be a direct result of body's declining ability to obtain and use oxygen. Marvlix slows down the aging process by enhancing oxygen utilization and cellular oxygen uptake.

 

In a recent study, Dr. Guo confirmed that Cordyceps usage increases cellular levels of adenosine triphosphate (ATP), the compound that consumes oxygen and releases energy in the cell. An increase in cellular ATP means a real increase in actual energy, energy that is available for use, as contrasted with the perceived increase in energy after use of central nervous system stimulants such as caffeine, ephedrine or amphetamines. A 2004 study by Dr. Zhu also showed that Cordyceps enhances oxygen utilization. 

One of the most amazing benefits of Marvlix is its anti-cancer effect. An increasing number of doctors worldwide recommend Cordyceps as an alternative, or addition, to chemotherapy, radiation, or other traditional cancer treatment.

 

Cordyceps has been used successfully to inhibit the growth of cancer cells, and to help dissolve cancerous tumors. 
 
In addition, clinical studies have proven that Cordyceps enhances and strengthens the immune system, enabling the body to manage its immune resources more efficiently while undergoing the stress of cancer attack.

 

This secondary effect is extremely important for patients going through chemotherapy or radiation treatment, strengthening the body against the toxic side effects of those treatments. It is no secret that many cancer patients die of opportunistic infections during chemotherapy rather than from the cancer itself. The use of Marvlix minimizes the risk of complication.

 

Many clinical studies of cancer patients have shown positive results. In one study, 50 lung cancer patients were treated with 6 grams of Cordyceps daily, in conjunction with chemotherapy. Tumors were reduced in size in 46% of the patients.

 

In a trial involving cancer patients with several different types of tumors, a majority of those treated for two months with 6 grams of Cordyceps daily, reported improved subjective symptoms. In approximately 50% of the patients, white blood cell counts remained high, while tumor size was significantly reduced.  

In addition to their benefits, many popular drugs are accompanied by considerable levels of toxicity. The incorporation of Marvlix into the treatment regimen will result in a significant reduction of toxicity or side effects from synthetic drugs, while sacrificing none of their efficacy.

 

Organ transplant cases offer a good example of how Cordyceps can be used in conjunction with pharmaceuticals.  
 
Cyclosporin is a drug frequently used in cases of organ transplant, but it is highly toxic. Many patients suffer serious kidney damage after using Cyclosporin. In a 1995 clinical study, 69 kidney transplant patients were given either Cyclosporin alone, or in conjunction with 3 grams of Cordyceps sinensis daily. After 15 days the group receiving Cyclosporin along with Cordyceps showed a much lower incidence of kidney failure than the group receiving Cyclosporin alone.

• Adults and children 12 years and over take two capsules 1-3 times daily
• Children under 12 take one capsule 1-2 times daily.
• No side effects, No drug interaction, no yeast, gluten or lactose
  

Jia-Shi Zhu, M.D., Ph.D. and James Rippe, M.D. (2004) Presented at the American Physiological Society's (APS) annual scientific conference, Experimental Biology 2003, held April 17-21, 2004, in Washington, D.C.

Shin KH, Lim SS, Lee S, Lee YS, Jung SH, Cho SY. (2003) Anti-tumour and immuno-stimulating activities of the fruiting bodies of Paecilomyces japonica, a new type of Cordyceps spp. Phytother Res. 2003 Aug; 17(7):830-3.

Koh JH, Yu KW, Suh HJ, Choi YM, Ahn TS. (2002) Activation of macrophages and the intestinal immune system by an orally administered decoction from cultured mycelia of Cordyceps sinensis. Biosci Biotechnol Biochem, 2002 Feb; 66(2):407-11.

Smith, Rowen and Sullivan (2002), Medicinal Mushrooms: Their Therapeutic Properties and Current Medical Usage with Special Emphasis on Cancer Treatment, May 2002; 106-141.

Hsu T. H., Shiao L. H., Hsiea C., and Chang D. M. 2002. A comparison of the chemical composition and bioactive ingredients of the Chinese medicinal mushroom DongChongXiaCao, its counterfeit and mimic, and fermented mycelium of Cordyceps sinensis. Food Chem, 78:463-469.

Wang, R., Xie, J., Ji, P., Li, S., Zhan, H., Xia, J., Sun, H., Lei, L., Yu, J., Wang, Y., Holliday, J., Clinical Trial report on Chronic Hepatitis treatment using Immune-Assist brand mushroom extract mixture in conjunction with the drug Lamivudine Wasser, S.P., (2002) Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol, 2002; 60:258-274.

Yue-Qin C, Ning W, Hui Z, Liang-Hu Q. (2002) Differentiation of medicinal Cordyceps species by rDNA ITS sequence analysis. Planta Med. 2002 Jul; 68(7):635-9.

Creadon, M. and Dam, J. (1996). " Drink up." Time (August 19): 55. a biologically active compound from cultures mycelia of Cordyceps and Isaria species. Phytochemistry, 22:2509-2512.

Gordon, D. (1993). : The rumored dope on Beijing's Women." Newsweek September 27): 63. Grey, P. and Barker, R. (1993). Cordyceps or plant eats animal! The Victorian Naturalist, 110:98-107.

Guan, Y.J., Hu, G., Hou, M., Jiang, H., Wang, X., and Zhang, C. (1992). Effect of Cordyceps sinensis on T- lymphocyte subsets in chronic renal railure. Chinese Journal of Integrated Medicine, 12:323, 338-339.

Guo, Y. Z. (1986). [Medicinal chemistry, pharmacology and clinical applications of fermented mycelia of Cordyceps sinensis and JinShuBao capsule]. Journal of Modern Diagnostics and Therapeutics, 1:60-65.

Guo QC, Zhang C. (1995) Clinical Observations of Adjunctive Treatment of 20 Diabetic Patients with JinSHuiBao Capsule. J Administration Traditional Chinese Medicine 1995; 5(suppl):22.

Bok JW, Lermer L, Chilton J, Klingeman HG, Towers GH., (1999) Antitumor sterols from the mycelia of Cordyceps sinensis. Phytochemistry 1999 Aug; 51(7):891-8.

Chamberlain, M. (1996). Ethnomycological experiences in South West China. Mycologist, 10 (4):173-176.

Chang, H.M. and But, P.P.H. (Eds.) (1986). Pharmacology and Applications of Chinese Materia Medica, 1. Philadelphia, PA: World Scientific, pp. 410-413.

Chen, J.R., Yen, J.H., Lin, C.C., Tsai, W.J., Liu, W.J., Tsai, J.J., Lin, S.F., and Liu, H.W. (1993). The effects of Chinese herbs on improving survival and inhibiting anti-ads DNA antibody production in lupus mice. American Journal of Chinese Medicine, 21:257-262. 

Chen K, Li C. (1993) Recent advances in studies on traditional Chinese anti-aging Materia Medica. J Tradit Chin Med 1993 Sep; 13(3):223-6.

Chen, S.Z. and Chu, J.Z. (1996). [NMR an IR studies on the characterization of cordycepin and 2'deoxyadenosine]. Zhongguo Kangshengsu Zaxhi, 21:9-12. 

Hammerschmidt, D.E. (1980). Szechwan purpura. New England Journal of Medicine, 302:1191-1193. 

Holliday, J., Cleaver, P., Loomis-Powers, M., and Patel, D., Analysis of Quality and Techniques for Hybridization of Medicinal Fungus Cordyceps sinensis, International Journal of Medicinal Mushrooms, Vol. 6, pp. 147-160 (2004).

Huang, Q., Li, D., Liang, J., Liao, S., and Liang S., (1991). [Weak polar chemical components in Cordyceps]. Journal of Chinese Medical Materials, 14:33-34.

Ikumoto, T., Sasaki, S., Namba, H., Toyama, R., Moritoki, H., and Mouri, T. (1991). [Physiologically active compounds in the extracts from tochukaso and cultured mycelia of Cordyceps and Isaria]. Yakugaku Zasshi, 111:504-509.

Huang , Y. et al (1987) Toxicology studies on cultured Cordyceps sinensis strain B414. Zhongchengyao Yanjiu 10:24-25 From Abstracts of Chinese Medicine, 2:321.

Chen, Y.Q., Wang, N., Qu, L., Li., T., and Zhang, W. (2001). Determination of the anamorph of Cordyceps sinensis inferred from the analysis of the ribosomal DNA internal transcribed spacers and 5.85 rDNA. Biochemical Systematics and Ecology, 29:597-607. 

Kadota, S., Shima, T., and Kikuchi, T. ( 1986) [Steroidal components of "I-Tiam-Hong" and Cordyceps sinensis. Separation and identification by high-performance liquid chromatography]. Yakugaku Zasshi, 106:1092-1097.

Kiho, T., Tabata , H., Ukai, S., and Hara, C., (1986). A minor protein-containing galactomannan from a sodium carbonate extracted of Cordyceps sinensis. Corbohydrate Reseach, 156:189-197.

Kiho T, Hui J, Yamane A, Ukai S. (1993) Hypoglycemic activity and chemical properties of a polysaccharide from the cultural mycelium of Cordyceps sinensis. Biol Pharm Bull 1993 Dec; 16(12):1291-3.

Kiho T, Yamane A, Hui J, Usui S, Ukai S. (2000) Hypoglycemic activity of a polysaccharide (CS-F30) from the cultural mycelium of Cordyceps sinensis and its effect on glucose metabolism in mouse liver. Phytother Res 2000 Dec; 14(8):647-9.

Kuo, Y.C., Tsai, W.J., Shiao, M.S., Chen, C.F., and Lin, C.Y. (1996) Cordyceps sinensis as an immunomodulatary agent. American Journal of Chinese Medicine, 24:111-125.

Kuo, Y.C., Tsai, W.J., Wang , J.Y., Chang, S.C., Lin, C.Y., and Shiao, M.S. (2001). Regulation of bronchoalveolar lavage fluids cell function by the immunomodulatory agents from Cordyceps sinensis. Life Sciences, 68:1067-1082.

Hawksworth D. L., et al. 1995 Ainsworth and Bisbi's Dictionary of the Fungi: 8th ed. International, University Press and Cambridge, 616 pp.

Hirose K., and Yahagi N. 1997. Japan tochukaso, Shock to Disappear of Cancer. Metamoru shyupan, Tokyo, 175 pp.

Itami H., and Yahagi N. 1996. Japan tochukaso, Challenge for Terminal Cancer. Metamoru shyupan, Tokyo, 140pp. 

Jiang, JC, Gao, YF. Summary of treatment of 37 chronic renal disfunction patients with JinShuiBao. J Administration Traditional Chinese Med 1995; 5(suppl):23-24.

Kiho T., and Ukai S. 1995. Tochukaso (Semitake and others), Cordyceps species. Food Rev Int, 11, 231-234. 

Kiho T., Hui, J., Yamane A., and Ukai S. 1993. Hypoglycemic activity and chemical properties of a polysaccharide from the cultural medium of Cordyceps sinensis. Bio Pharmacol Bull, 16:1291-1293. 

Hiho T., Yamane A., Hui J., Usui S., and Ukai S. 1996. Hypoglycemic activity of a polysaccharide (CS-F30) from the cultural mycelium of Cordyceps sinensis and its effect on glucose metabolism in mouse liver. Biol Pharmacol Bull, 19:294-296.

Kobayashi Y., and Shimizu D., 1983. Iconography of Vegetable Wasps and Plant Worms. Hoikusha Tokyo, 208 pp.

Kubo M. 1996 Tochukaso. Its secret and its Power. Hoikusha,, Tokyo, pp. 128, 152. Li, L.S. and Zheng, F. (1992). Clinical protection of aminoglycoside neophrotoxiciry by Cordyceps sinensis (CS). Journal of the American Society of Nephrology, 3:726 (ABSTRACT 24p).

Liu FA, Zheng X, (1993) Study of Cordyceps sinensis on anti-laryngeal carcinoma. J. Norman Bethune University Med Sci, 1993; 19(1):57-58.

Liu, C., Xue, HM., Xu, LM., Zhao, PZ., Zhang, LB., Tang, MG., Treatment of 22 patients with post hepatic cirrhosis with a preparation of fermented mycelia of Cordyceps sinensis. Shanghai J Chinese Materia Medica, 1986; 6:30-31.

Leung, A.K., Gong, F., and Chau, F. (2000). Analysis of the water soluble constituents of Cordyceps sinensis with heuristic evolving latent projections. Analytical Letters, 33:3195-3211.

The Merck Index, 11 Edition, 1989. 2524 Cordycepin. Merk and Co., 395 pp.

Mizuno T.1997. Development and ultilization of bioactive substances from medical and edible mushrooms fungi (10) Charga, Sclerotiana of Fuscopotia oblique (Fr) Aoshima. The Chemical Times, 163:9-15. 

Mizuno T. 1998. Immunological Diet for Cancer Serious Disease. Gendaishorin, Tokyo, 188 pp.

Nakamura K, Yamaguchi Y, Kagota S, Shinozuka K, Kunitomo M., Activation of in-vivo Kupffer cell function by oral administration of Cordyceps sinensis in rats. (1999) Jpn J Pharmacol, 1999 Apr;79(4):505-8.

Nakamura K, Konoha K, Yamaguchi Y, Kagota S, Shinozuka K, Kunitomo M. (2003) Combined effects of Cordyceps sinensis and methotrexate on hematogenic lung metastasis in mice. Receptors Channels, 2003; 9(5):329-34 .

Ohmori T., Tamura K., Tsuru S., and Nomoto K., 1986. Antitumor activity of protein-blood polysaccharide from Cordyceps ophioglossoides in mice. Jnp J Cancer Res (Gann), 77:1256-1263.

Ohmori T., Tamura K., Furuki K., Kawanishi G., Mitsuyama M., Nomoto K., Miyazaki t, 1989. Isolation of galactosaminoglycan moity (CO-N) from protein-bound polysaccharide of Cordyceps ophioglossoides and its effects against murine tumor. Chem Pharmacol Bull, 37:1019-1022.

Parcell AC, Smith JM, Schulthies SS, Myrer JW, Fellingham G. (2004) Cordyceps Sinensis (CordyMax Cs-4) supplementation does not improve endurance exercise performance. Int J Sport Nutr Exerc Metab. 2004 Apr; 14(2):236-42.

Pelleg, A., Porter, R.S. (1990) The pharmacology of adenosine. Pharmacotherapy, 1990; 10:157-174.

Shin KH, Lim SS, Lee SH, Lee YS, Cho SY (2001) Antioxidant and immunostimulating activities of the fruiting bodies of Paecilomyces japonica, a new type of Cordyceps sp. Ann N Y Acad Sci. 2001 Apr; 928:261-73.

Shimizu D. 1994. Color Iconography of Vegetable Wasps and Plant Worms. Seibundoshinksosha, Tokyo, 381 pp.

Suh SO, Noda H, Blackwell M (2001)Insect symbiosis: derivation of yeast-like endosymbionts within an entomopathogenic filamentous lineage. Mol Biol Evol. 2001 Jun; 18(6):995-1000.

Takeuchi N. 1998. Pharmacological effect of Tochukaso and its utilization for food. Kagaku to Kogyo, 51:1614-161.

Toda, N., Okunishi, H., Taniyama, K., Miyazaki, M., (1982) Response to adenine nucleotides and related compounds of isolated dog cereberal, coronary and mesenteric arteries. Blood Vessels, 1982; 19:226-236.

Ukai S, Kiho T, Hara C, Morita M, Goto A, Imaizumi N, Hasegawa Y (1983) Polysaccharides in fungi: XIII. Antitumor activity of various polysaccharides isolated from Dictyophora indusiata, Ganoderma japonicum, Cordyceps cicadae, Auricularia uricula-judae and Auricularia sp. Chem Pharma Bull (Tokyo), 31:741-744.

Yamanaka K., and Inatomi S, 1997. Cultivation of Isaria japonica fruit bodies on mixed plant/insect media. Food Rev Int, 13:455-460.

Segelken, R. (2002) Cyclosporin mold's 'sexual state' found in New York forest Cornell students' discovery could target additional sources of nature-based pharmaceuticals Cornell University Science News, Sept 16, 1996.

Tai-Hao, H., Hui-Chen, L., Biological activity of Cordyceps (Fr.) Link Species (Ascomycetes) Derived from a Natural Source and from Fermented Mycelia on Diabetes in STZ-Induced Rats. Inter J of Med Mush, 4:111-125.

Xu, W.Z., Wei, J.P., Wang N. Q., Liu T., (1988) Experimental study of the combined chemotherapy of Zhiling Capsules and Anticancer agents. Shanghai Zhongyiyao Zazhi 1988; (6):48.

Xu, F., Huang JB., Jiang, L., Xu, J., Mi, J., (1995) Amelioration of cyclosporin nephrotoxicity by Cordyceps sinensis in kidney transplanted recipients. Nephrol Dial Transplant 1995; 10(1):142-143.

Yamada H., Kawaguchi N., Ohmori T., Takeshita Y., Teneya S., and Miyazaji t. 1984. Structure and antitumor activity if an alkali-soluble polysaccharide from Cordyceps ophioglossoides. Carbohydr Res, 125, 107-115. 

Yamaguchi N., et al, (1990) Augmentation of various immune reactivities of tumor bearing hosts with an extract of Cordyceps sinensis. Biotherapy, 2:199-205.

Yang, YZ., Wang, LS., Deng, HY., Ma, YS., Wu, HS., Short term observation of treating chronic hepatitis B and post hepatic cirrhosis with XinGanBao. Res Chinese Materia Medica 1994; 1:19-20. 

Yoshida J et al (1989) Antitumor activity of an extract of Cordyceps sinensis (Berk.) Sacc. Against murine tumor cell lines Jpn J Exp Med, 59:157-161.

Zhao CS, Yin WT, Wang JY, Zhang Y, Yu H, Cooper R, Smidt C, Zhu JS. (2002) Cordyceps Cs-4 improves glucose metabolism and increases insulin sensitivity in normal rats. J Altern Complement Med. 2002 Aug; 8(4):403-5. 

Halpern, G., (1999) Cordyceps, Chinas healing mushroom. Avery Publishig 1999: 63-70 Bao, Z.D., Wu, Z.G., and Zheng, F. (1994). [Amelioration of aminoglycoside nephrotoxicity by Cordyceps Sinensis in old patients]. Chinese Journal of Integrated Medicine, 14:259,271-273.

Berne, R.M., 1980: The role of Adenosine in the regulation of coronary blood flow. Circ. Res. 1980; 47:807-813.

Wu T. N., Yang K. C., Wang C. M., Lai J. S., Ko K. N., Chang P. Y., and Liou S. H. 1996. Lead poisoning caused by contaminated Cordyceps, a Chinese herbal medicine: two case reports. Sci Total Environ, 182, 193-195.

• Cutting-Edge Nanotechnology
• Aids  in the treatment of lung, kidney, liver, heart disease. cancer, diabetes, high cholesterol, the effects of aging, and the reduction of drug toxicity
• Numerous clinical trials have proven scientifically that Cordyceps works well in treating and healing a myriad of medical problems
• Marvlix is an updated version of Cordyceps sinensis produced through our proprietary method.